Jazz Pharmaceuticals, Inc.
31Patents
30Active
31Granted
55Portfolio score
Filing activity: Jul 13, 2007 → Jul 20, 2021 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263650B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 107 | Active |
| US7895059B2 | Sensitive drug distribution system and method | Physics | 97 | Active |
| US8778398B2 | Immediate release formulations and dosage forms of gamma-hydroxybutyrate | Human Necessities | 87 | Active |
| US8324275B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 86 | Active |
| US7851506B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 85 | Active |
| US8457988B1 | Sensitive drug distribution system and method | Physics | 83 | Active |
| US8591922B1 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Human Necessities | 82 | Active |
| US8589182B1 | Sensitive drug distribution system and method | Physics | 78 | Active |
| US8731963B1 | Sensitive drug distribution system and method | Physics | 78 | Active |
| US8952062B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 77 | Active |
| US8901173B2 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Human Necessities | 71 | Active |
| US8772306B1 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Physics | 70 | Active |
| US8461203B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 69 | Active |
| US8859619B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 67 | Active |
| US8771735B2 | Immediate release dosage forms of sodium oxybate | Human Necessities | 59 | Active |
| US9539330B2 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Human Necessities | 57 | Active |
| US9795567B2 | Immediate release formulations and dosage forms of gamma-hydroxybutyrate | Human Necessities | 54 | Active |
| US10813885B1 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 50 | Active |
| US10758488B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 49 | Active |
| US9801852B2 | Devices and methods for facilitating and controlling use of a medication | Human Necessities | 48 | Active |
| US10959956B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 47 | Active |
| US10966931B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 47 | Active |
| US11090269B1 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 45 | Active |
| US10987310B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 44 | Active |
| US11207270B2 | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances | Human Necessities | 40 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.